LINC 2018 presentations


LINC 2018, the Leipzig Interventional Course,  will feature state-of-the-art lectures and numerous live cases performed from leading interventional centers.

LINC 2018 took place from Tuesday, January 30 through Friday, February 2, 2018.

Room 5 - Global Expert Exchange

15 events
  • Tuesday, January 30th: - , Room 5 - Global Expert Exchange

    CCT@LINC

    Moderator:
    Giancarlo Biamino, Kazushi Urasawa
    Panel:
    Hiroshi Ando, Tatsuya Nakama, Osamu Iida
    1. -

      Introduction

    2. -

      Video live and lecture: How to cross below-the-knee CTO

        Hiroshi Ando
    3. -

      Video live and lecture: How to cross below-the-ankle CTO

        Tatsuya Nakama
    4. -

      Video live and lecture: How to cross SFA CTO/Japanese evidences

        Osamu Iida
    5. -

      Video live and lecture: How to cross SFA CTO/Japanese techniques

        Kazushi Urasawa
    6. -

      Discussion and conclusion

  • Tuesday, January 30th: - , Room 5 - Global Expert Exchange

    LUNCH SYMPOSIUM: DCB or stent? The latest data to influence your decision

    Moderator:
    Koen Deloose
    1. -

      Luminor DCB makes it different and favourable in CLI (LUMINOR registry, 12-month data)

        Vicente Riambau
    2. -

      Is there still any space left for DES? (ANGIOLITE BTK trial, 6-month data)

        Peter Goverde
    3. -

      Discussion: BTK

    4. -

      Is Luminor DCB the best choice for femoropopliteal lesions? (EFFPAC–RCT, 6-month data)

        Ulf Teichgräber
    5. -

      Or is the iVolution stent a better alternative? (EVOLUTION study, 12-month data)

        Marc Bosiers
    6. -

      Femoropopliteal arteries discussion

  • Tuesday, January 30th: - , Room 5 - Global Expert Exchange

    Clinical approaches and techniques in the management of CLI diabetic patients

    Moderator:
    Marco Manzi, Gary Ansel
    Panel:
    Eric Ducasse, Francesco Liistro
    1. -

      The specifics of diabetic macroangiopathy: What is different from atherosclerosis and how does it contribute to critical limb ischemia?

        Raghu Kolluri
    2. -

      The multidisciplinary approach in BTK intervention in DM patients: the right road to success

        Katja Mühlberg
    3. -

      Factors affecting outcome of CLI procedures

        Osamu Iida
    4. -

      Timing is all in CLI diabetic patients: planning a winning strategy for limb salvage

        Roberto Ferraresi
    5. -

      Live case transmission from Berlin

        Sankt-Gertrauden-Hospital Berlin - Live case center
    6. -

      Latest techniques and results in BTK interventions

        Marco Manzi
    7. DEBATE ON STUDY RESULTS VS. DAILY PRACTICE IN BTK INTERVENTIONS:

    8. -

      Use of DCB in BTK – CONTRA

        Gary Ansel
    9. -

      Use of DCB in BTK – PRO

        Francesco Liistro
    10. -

      Use of DES in BTK – CONTRA

        TBD
    11. -

      Use of DES in BTK – PRO

        Dimitrios Karnabatidis
    12. -

      Is 2018 the right moment to try to harmonize BTK intervention approaches?

        Eric Ducasse
    13. -

      Are the coronary outcomes of BVS relevant to BTK applications?

        Brian DeRubertis
  • Tuesday, January 30th: - , Room 5 - Global Expert Exchange

    CLI-Therapies-LINCed – Multidisciplinary case studies from centres of excellence

    Moderator:
    Marianne Brodmann, Steven Kum
    Panel:
    Osamu Iida, Michiel Schreve
    1. MANAGING THE INFECTED WOUND

    2. -

      How do you prioritize revascularisation vs. treatment of infection – presentation and a case example

        Michiel Schreve
    3. -

      Questions and answers

    4. ANGIOSOME DIRECTED THERAPY

    5. -

      Angiosome concept – myth or truth? Does it make a real difference in “real world” cases? Presentation and a case example

        Osamu Iida
    6. -

      Questions and answers

    7. THE "MOTHER OF ALL CLIs" – THE RUTHERFORD 6 WOUND

    8. -

      Managing R6 wounds – the utility of multi-vessel revascularisation and inflow strategies – presentation and a case example

        Peter Schneider
    9. -

      Questions and answers

    10. CLI IN DIALYSIS – A SPECIAL BREED OF PATIENTS

    11. -

      Plantar arch and below-the-ankle angioplasty – who, when, and how? Presentation and a case example

        Marco Manzi
    12. -

      Questions and answers

    13. END STAGE NO OPTION CLI – MAKING SWEET DESSERT OUT OF THE DESERT FOOT

    14. -

      Percutaneous deep venous arterialisation with the LimFlow procedure – presentation and a case example

        Marianne Brodmann
    15. -

      Questions and answers

  • Wednesday, January 31st: - , Room 5 - Global Expert Exchange

    Deep dive session: Lower limb interventions (part I) – Focus on vessel preparation and drug-coated balloons

    Moderator:
    Tony Das, Iris Baumgartner-Peuker
    Panel:
    George Adams, Hans Krankenberg
    1. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    2. -

      What is vessel preparation and how have the DEFINITIVE LE and DEFINITVE AR results influenced current practice?

        Lawrence Garcia
    3. -

      What have we learned so far in the REALITY study?

        Krishna Rocha-Singh
    4. -

      Laser in practice: defining the right settings across different lesion morphologies

        George Adams
    5. -

      The PRELUDE study: PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator® DevicE

        Andrew Holden
    6. -

      Comparison of particulate embolisation in different DCB formulations

        Aloke Finn
    7. -

      Real-world experience with a Paclitaxel Coated Balloon for the treatment of atherosclerotic infrainguinal arteries. Twelve-month results of the BIOLUX P-III All Comers Registry in diabetic patients

        Marianne Brodmann
    8. -

      12-month results from the IN.PACT DCB in a Chinese population

        Wei Guo
    9. -

      12-month results with the ORCHID DCB: The Leipzig experience

        Sabine Steiner
    10. -

      The role of DCB in Korea practice: LUTONIX DCB Korean registry 1-year data in fem-popliteal arteries

        Jae Kyu Kim
    11. -

      First Report of the SELUTION Trial: 6-month 0utcomes of a Novel Sirolimus Coated DCB Technology Evaluated in SFA

        Thomas Zeller
    12. -

      The LEGDEB registry – 12-month results with the Legflow® DCB in femoropopliteal de novo and restenotic lesions

        Eugenio Stabile
    13. -

      Impact of gender on outcomes: Review of the IN.PACT SFA 3-year results

        Maureen Kohi
    14. -

      Drug coated balloons vs. BMS for the treatment of femoropopliteal lesions

        Hans Krankenberg
    15. -

      Health economic analysis of DCB use in Belgium: Implications for practice

        Frank Vermassen
    16. -

      Discussion and conclusion

  • Wednesday, January 31st: - , Room 5 - Global Expert Exchange

    JET@LINC

    Moderator:
    Giancarlo Biamino, Yoshiaki Yokoi, Hiroyoshi Yokoi
    Panel:
    Kazushi Urasawa, Osamu Iida
    1. -

      Introduction

    2. -

      Aorto-Iliac artery disease treated with endovascular therapy (EVT) of stent placement; multicenter prospective registry in Japan: OMOTENASHI

        Yasutaka Yamauchi
    3. -

      Peripheral artery CTO crossing in Japan

        Kazushi Urasawa
    4. -

      Challenges for calcified complex SFA lesion assessed by intravascular ultrasound

        Masahiko Fujihara
    5. -

      Ideal strategy for long SFA-CTO according to pathological findings

        Daizo Kawasaki
    6. -

      Optimal endpoint of BTK intervention for wound healing

        Makoto Utsunomiya
    7. -

      Decision making of treatment strategy in patients with CLI, learn from Priority and SPINACH study

        Osamu Iida
    8. -

      Discussion and conclusion

  • Wednesday, January 31st: - , Room 5 - Global Expert Exchange

    Deep dive session: Lower limb interventions (part II) – Focus on Combination therapies and new implants

    Moderator:
    Giancarlo Biamino, Krishna Rocha-Singh
    Panel:
    Hiroyoshi Yokoi
    1. -

      Clinical plasticity of PLLA – Novel BioResorbable vascular platforms from India

        Arne Schwindt
    2. -

      FIRST TIME DATA RELEASE: Outcomes at 2 years in stented vs. non-stented patients post-DCB: A subanalysis from the IN.PACT Global study

        Gary Ansel
    3. -

      FIRST TIME DATA RELEASE: Real PTX RCT: 3 year data from a randomized comparison of DCB vs. DES in femoropopliteal lesions

        Dierk Scheinert
    4. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    5. -

      Directional Atherectomy and Anti-Restenotic Therapy (DAART) in multilevel disease

        Carlos Abel Gutierrez Diaz
    6. -

      Combination therapy with atherectomy followed by DCB: 1-year outcomes with Lutonix DCB and 1-year outcomes with IN.PACT DCB

        Louis Lopez
    7. -

      12-month and preliminary 24-month outcomes of combining a DCB with a modern generation of nitinol stent in femoropopliteal lesions: analysis of the BIOLUX 4 EVER study

        Lieven Maene
    8. -

      Short-term results of the RAPID Randomised trial of the Legflow® paclitaxel-eluting balloon with supera stenting vs. supera stenting alone for the treatment of intermediate and long superficial femoral artery lesions

        Daniel van den Heuvel
    9. -

      Combination of Supera DCB in revascularisation of long femoropopliteal occlusions. Single center experience

        Anish Thomas
    10. -

      12-month outcomes in the EVOLUTION study: Investigating the iVolution stent in femoropopliteal lesions

        Marc Bosiers
    11. -

      Impact of Zilver PTX after stent implantation for femoropopliteal lesions for 2-year follow up. How to maximize performance of Zilver PTX

        Eiji Ojima
    12. -

      The clinical comparison of Zilver PTX and Innova for femoropopliteal lesions in Japanese single center

        Kenji Ogata
    13. -

      The Supera stent in retrograde vascular access for SFA ostium treatment: The SUPRA-FAST registry

        Vincenzo Pestrichella
    14. -

      Laser and DCB for SFA ISR: follow-up of a single center cohort up to 5 years

        Jos van den Berg
    15. -

      LIBERTY 360: Predictors of 1-year outcomes of endovascular device interventions in patients with symptomatic lower extremity peripheral artery disease

        William Gray
    16. -

      Discussion and conclusion

  • Wednesday, January 31st: - , Room 5 - Global Expert Exchange

    LUNCH SYMPOSIUM: New options and treatment times with EKOS™ Acoustic Pulse Thrombolysis™

    Moderator:
    Nils Kucher
    Panel:
    Mark J. Garcia, Keith M. Sterling, Nima Hatam
    1. -

      Introduction

    2. -

      Access PTS – How do I treat my PTS patients?

        Mark J. Garcia
    3. -

      The OPTALYSE PE Trial – Reducing thrombolytic dose and treatment times with EKOS™ in the treatment of pulmonary embolism patients

        Keith M. Sterling
    4. -

      The surgeon's perspective on PE

        Nima Hatam
    5. -

      Discussion and conclusion

  • Wednesday, January 31st: - , Room 5 - Global Expert Exchange

    Expert opinion on deep venous stenting – patient selection, technique, and clinical outcomes

    Moderator:
    Stephen Black
    Panel:
    Michael Lichtenberg, Olivier Hartung
    1. -

      Introduction

    2. -

      Venous stenting experience in Arnsberg

        Michael Lichtenberg
    3. -

      Venous stenting experience in Modena – video presentation

        Marzia Lugli, Video presentation
    4. -

      Venous stenting experience in Marseille

        Olivier Hartung
    5. -

      Discussion and conclusion

  • Wednesday, January 31st: - , Room 5 - Global Expert Exchange

    DEEP DIVE SESSION: Endovenous therapies – Part I

    Moderator:
    Nils Kucher, Stephen Black
    Panel:
    Steven Kum, Rick de Graaf
    1. FOCUS ON IVC FILTERS

    2. -

      Pros and cons of IVC filter implantation: What are the established indications?

        Robert Lookstein
    3. -

      Challenging case: Massive thromboembolism trapped in IVC filter during total hip replacement arthroplasty

        Yang Jin Park
    4. -

      Tips and tricks for challenging and complex IVC filter

        Fakhir Elmasri
    5. -

      To worry or not to worry with a ruptured inferior vena cava post IVC filter removal

        Christopher Stout
    6. FOCUS ON DEEP VEIN RECANALISATION

    7. -

      CTV vs. MRV for imaging of venous disease

        Jos van den Berg
    8. -

      Recorded case presentation

        Nils Kucher
    9. -

      Assessing the CFV – do I need to perform an endophlebectomy or not

        Antonio Rosales
    10. -

      Where to include IVUS in optimal venous diagnostic treatment pathway

        Erin Murphy
    11. -

      Radiation dose in venous procedures how do we actively reduce this

        Gerard O'Sullivan
    12. -

      Is there a place for endovascular therapy of acute venous thrombosis after ATTRACT?

        Oliver Schlager
    13. -

      Single session pharmaco-mechanical venous thrombectomy – how to do it!

        Gerard O'Sullivan
    14. -

      Evidence on mechanical thrombectomy for iliofemoral DVT

        Michael Lichtenberg
    15. -

      Assessing adequate clot removal after lysis – when are you done and decision making in what stent

        Stephen Black
    16. -

      Discussion and conclusion

  • Wednesday, January 31st: - , Room 5 - Global Expert Exchange

    Deep dive session: Endovenous therapies – Part II

    Moderator:
    Gerard O'Sullivan, Erin Murphy
    Panel:
    Raghu Kolluri, Matthias Ulrich, Karin Brachmann
    1. TOWARDS NEW VENOUS STENT DESIGNS: A DEVICE PARADE

    2. -

      VIVO EU and VIVO US: experience with the ZILVER VENA stent

        Gerard O'Sullivan
    3. -

      Building clinical evidence: Update on the ABRE study

        Stephen Black
    4. -

      VENOVO® Venous stent – Update on the Vernacular trial

        Houman Jalaie
    5. -

      Patency rates and clinical results of the Venovo venous stent in a real world registry

        Michael Lichtenberg
    6. -

      Patency rates and clinical results of the Veniti VICI stent for the treatment of iliac vein lesion

        Michael Lichtenberg
    7. -

      The bifurcation stent: Sinus obliqus

        Torsten Fuß
    8. -

      Matching the right venous stent to your patient and their individual anatomy

        Ramon Varcoe
    9. -

      How to use anatomical landmarks only to precisely position left common iliac venous stents at the IVC confluence

        Gerard O'Sullivan
    10. -

      Re-intervention in venous stents – causes, identification, and solution

        Rick de Graaf
    11. FOCUS ON SUPERFICIAL VENOUS DISEASE

    12. -

      Diagnostic workup prior to ablation therapy of superficial venous disease

        Anina Lukhaup
    13. -

      VeClose trial: Cyanoacrylate closure vs. RF ablation 36-month results

        Tobias Hirsch
    14. -

      Laser technology: latest developments

        Matthias Ulrich
    15. -

      Managing the challenging patient: Ancillary procedures for complex anatomies

        Raghu Kolluri
    16. -

      Panel discussion

  • Thursday, February 1st: - , Room 5 - Global Expert Exchange

    Global expert exchange: Selected challenging cases and complications

    Moderator:
    Giancarlo Biamino, Ramon Varcoe
    Panel:
    Ulf Teichgräber, Ayman Al-Sibaie
    1. -

      Venous and AV access

    2. -

      Application of drug coated balloon angioplasty for pulmonary vein stenosis. Novel approach

        Bhaskar Purushottam
    3. -

      Acute phlegmasia cerulea dolens related to complete subacute occlusion of the entire left LE deep venous system in the setting of typical May-Thurner syndrome

        Hady Lichaa
    4. -

      Pseudoaneurysm after IVC filter removal

        John Phillips
    5. -

      Critical limb ischemia

    6. -

      Creation of a multidisciplinary limb preservation program improves limb salvage and increases endovascular volume in a tertiary referral center

        David O'Connor
    7. -

      Feasibility and outcomes of delay revascularization in patients with PAD and tissue loss

        Christian Bianchi
    8. -

      Management of diabetic foot with toe gangrene and severe arterial disease

        Ahmed Kayssi
    9. -

      Impact of hemodialysis on outcomes for patients with CLI: Assessment using the WIfI classification

        Shin Okamoto
    10. -

      Hybrid treatment of aortoiliac and femoral occlusion for patients with critical limb ischemia

        Jang Yong Kim
    11. -

      Telehealth use in wound care

        John Phillips
    12. -

      Visceral, renal and mesenteric

    13. -

      Treatment of a pancreaticoduodenal arcade aneurysm with a flow modulator stent

        Lucas Freire
    14. -

      Persistent sciatic artery aneurysm treated with a use of VIABAHN endoprosthesis

        Shigeo Ichihashi
    15. -

      A case of successfully treated penaile ischimic ulcer by internal pudendal artery plasty in a hemodialysis patient

        Tomoyasu Sato
    16. -

      Management of spontaneous isolated dissection of the superior mesenteric artery

        Hwan Jun Jae
    17. -

      Renal denervation in Korea

        In-Ho Chae
    18. -

      Renal thrombectomy and vena stent

        Roberto Beck
    19. -

      Discussion and conclusion

  • Thursday, February 1st: - , Room 5 - Global Expert Exchange

    Nurse and Technician Forum – Part I

    Moderator:
    Martin Werner, Lieven Maene
    1. MY MOST INTERESTING CASE

    2. -

      Carotid stenting

        Gianmarco de Donato
    3. -

      Complex femoropoliteal case

        Koen Deloose
    4. -

      Endovascular aortic repair

        Tilo Kölbel
    5. -

      Infrapopliteal recanalisation

        Jean Marc Pernes
    6. -

      Discussion

    7. ADVANCED TECHNOLOGIES IN PERIPHERAL INTERVENTIONS

    8. -

      Optical coherence tomography in peripheral interventions

        Konstantinos Stavroulakis
    9. -

      Radiation protection – from global to local

        Alexander Gangl
    10. -

      Drug eluting balloons: Update

        Axel Fischer
    11. -

      Drug eluting stents: Update

        Bärbel Berekoven
    12. -

      Adventitial drug infusion to prevent restenosis

        Marianne Brodmann
    13. -

      Discussion

  • Thursday, February 1st: - , Room 5 - Global Expert Exchange

    Lunch symposium: BioMimics 3D®: The importance of Swirling Flow® in treating atherosclerosis and preventing restenosis in femoropopliteal arteries

    Moderator:
    Gary Ansel
    Panel:
    Timothy Sullivan, Michael Lichtenberg
    1. -

      Introduction by the moderator

    2. -

      The science behind Swirling Flow®

        Timothy Sullivan
    3. -

      1-year results from the MIMICS-2 study

        Thomas Zeller, Via satellite from Bad Krozingen
    4. -

      Two techniques to limit restenosis – drugs and Swirling Flow®

        Gary Ansel
    5. -

      BioMimics 3D in my clinical practice

        Michael Lichtenberg
    6. -

      Discussion

  • Thursday, February 1st: - , Room 5 - Global Expert Exchange

    Nurse and Technician Forum – Part II

    Moderator:
    Theodosios Bisdas, Oliver Schlager
    1. MISCELLANEOUS

    2. -

      Diagnostic steps in cerebral arterial disease

        TBD
    3. -

      Reducing contrast induced renal insufficiency

        Daniela Branzan
    4. -

      Radiation safety

        Konstantinos Katsanos
    5. -

      Stenting or surgery for common femoral artery stenosis

        Yann Gouëffic
    6. -

      Venous stenting

        Oliver Schlager
    7. -

      Endoluminal treatment of varicose veins

        Anina Lukhaup
    8. -

      Discussion

    9. CRITICAL LIMB ISCHEMIA

    10. -

      Improving CLI care – A multidisciplinary challenge

        Katja Mühlberg
    11. -

      Non invasive diagnosis in CLI

        Oliver Schlager
    12. -

      Assessment of microcirculation in CLI

        Miguel Montero-Baker
    13. -

      Cardiovascular disease in CLI patients

        Corneliu Popescu
    14. -

      Discussion